Global
# |
Name |
Dividend Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
5,336.68% |
Jan. 14, 2025 | USD 1.21 | NA |
|
United States |
|
2 |
892.64% |
Jan. 14, 2025 | USD 342.23 | -2.69% |
|
United States |
|
3 |
380.96% |
Jan. 14, 2025 | USD 6.35 | 5.83% |
|
United States |
|
4 |
127.27% |
Jan. 14, 2025 | USD 2.75 | 1.10% |
|
United States |
|
5 |
74.62% |
Jan. 14, 2025 | USD 3.53 | 5.69% |
|
United States |
|
6 |
61.79% |
Jan. 14, 2025 | USD 1.05 | 3.96% |
|
United States |
|
7 |
54.11% |
Jan. 14, 2025 | USD 40.10 | -0.57% |
|
Poland |
|
8 |
45.49% |
Jan. 14, 2025 | USD 0.84 | -1.42% |
|
South Africa |
|
9 |
45.12% |
Jan. 14, 2025 | USD 27.83 | 2.50% |
|
France |
|
10 |
39.68% |
Jan. 14, 2025 | USD 0.18 | -0.02% |
|
Hong Kong |
|
11 |
34.77% |
Jan. 14, 2025 | USD 2.14 | -2.28% |
|
United States |
|
12 |
32.21% |
Jan. 14, 2025 | USD 1.81 | 2.26% |
|
United States |
|
13 |
31.54% |
Jan. 10, 2025 | USD 1.23 | -0.57% |
|
Portugal |
|
14 |
31.49% |
Jan. 14, 2025 | USD 0.79 | 3.04% |
|
China |
|
15 |
30.49% |
Jan. 14, 2025 | USD 10.98 | -0.31% |
|
South Korea |
|
16 |
24.61% |
Jan. 14, 2025 | USD 1.65 | 2.58% |
|
Mexico |
|
17 |
22.07% |
Jan. 14, 2025 | USD 21.87 | -3.36% |
|
United States |
|
18 |
21.25% |
Jan. 14, 2025 | USD 1.34 | 2.44% |
|
Brazil |
|
19 |
20.73% |
Jan. 14, 2025 | USD 3.33 | 0.41% |
|
Sweden |
|
20 |
17.42% |
Jan. 14, 2025 | USD 25.97 | 0.60% |
|
Germany |
|
21 |
15.19% |
Jan. 14, 2025 | USD 0.70 | 2.41% |
|
China |
|
22 |
14.46% |
Jan. 14, 2025 | USD 2.46 | 1.36% |
|
China |
|
23 |
13.23% |
Jan. 14, 2025 | USD 20.20 | -1.60% |
|
Germany |
|
24 |
12.88% |
Jan. 14, 2025 | USD 1.19 | 1.67% |
|
Taiwan |
|
25 |
12.88% |
Jan. 14, 2025 | USD 11.90 | 21.74% |
|
South Korea |
|
26 |
12.87% |
Jan. 14, 2025 | USD 1.90 | -3.55% |
|
United States |
|
27 |
12.11% |
Jan. 14, 2025 | USD 7.82 | 0.51% |
|
United States |
|
28 |
11.53% |
Jan. 14, 2025 | USD 0.40 | -0.34% |
|
China |
|
29 |
11.36% |
Jan. 14, 2025 | USD 1.49 | -0.76% |
|
Germany |
|
30 |
11.23% |
Jan. 14, 2025 | USD 1.10 | 2.94% |
|
China |
|
31 |
11.18% |
Jan. 14, 2025 | USD 3.77 | 2.84% |
|
China |
|
32 |
11.05% |
Jan. 14, 2025 | USD 0.79 | 2.66% |
|
China |
|
33 |
10.89% |
Jan. 14, 2025 | USD 0.66 | 2.10% |
|
China |
|
34 |
10.76% |
Jan. 14, 2025 | USD 0.67 | 0.94% |
|
China |
|
35 |
10.64% |
Jan. 14, 2025 | USD 1.91 | 0.06% |
|
France |
|
36 |
10.51% |
Jan. 14, 2025 | USD 8.86 | 3.31% |
|
China |
|
37 |
10.42% |
Jan. 14, 2025 | USD 5.68 | 4.11% |
|
Sweden |
|
38 |
10.35% |
Jan. 14, 2025 | USD 0.16 | -0.02% |
|
China |
|
39 |
10.23% |
Jan. 14, 2025 | USD 0.06 | 1.49% |
|
Indonesia |
|
40 |
10.07% |
Jan. 14, 2025 | USD 1.91 | 1.25% |
|
Brazil |
|
41 |
10.03% |
Jan. 14, 2025 | USD 12.24 | 2.86% |
|
United States |
|
42 |
9.93% |
Jan. 14, 2025 | USD 0.16 | 1.27% |
|
Indonesia |
|
43 |
9.86% |
Jan. 14, 2025 | USD 5.09 | 2.06% |
|
China |
|
44 |
9.77% |
Jan. 14, 2025 | USD 0.65 | 2.15% |
|
China |
|
45 |
9.70% |
Jan. 14, 2025 | USD 0.21 | -1.79% |
|
Indonesia |
|
46 |
9.43% |
Jan. 14, 2025 | USD 2.05 | 0.07% |
|
South Korea |
|
47 |
9.35% |
Jan. 14, 2025 | USD 9.59 | -1.93% |
|
Japan |
|
48 |
9.33% |
Jan. 14, 2025 | USD 0.14 | 3.12% |
|
Indonesia |
|
49 |
9.22% |
Jan. 14, 2025 | USD 0.59 | 1.41% |
|
China |
|
50 |
8.75% |
Jan. 14, 2025 | USD 0.91 | -0.72% |
|
Hong Kong |
The Health Care company with the highest Dividend Yield is IMAC Holdings, Inc. (NasdaqCM: BACK) at 5,336.68%.
The Health Care company with the lowest Dividend Yield is Pyxis Oncology, Inc. (NasdaqGS: PYXS) at 0.00%.
The top 10 Health Care companies the Global by Dividend Yield are IMAC Holdings, Inc., Bio-Rad Laboratories, Inc., 22nd Century Group, Inc., MEI Pharma, Inc., Synaptogenix, Inc., Nuwellis, Inc., Scope Fluidics S.A., Life Healthcare Group Holdings Limited, Boiron SA and Jilin Province Huinan Changlong Bio-pharmacy Company Limited.
The bottom 10 Health Care companies by Dividend Yield are Pyxis Oncology, Inc., Biomea Fusion, Inc., PT Pyridam Farma Tbk, Guard Therapeutics International AB (publ), Sedana Medical AB (publ), Genelux Corporation, BioVie Inc., Haemonetics Corporation, Par Drugs and Chemicals Limited and Monte Rosa Therapeutics, Inc..